Zheng J - Search Results

1

Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma.

Reddel HK, O'Byrne PM, FitzGerald JM, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Puu M, Alagappan VKT, Bateman ED. Reddel HK, et al. Among authors: zheng j. J Allergy Clin Immunol Pract. 2021 Aug;9(8):3069-3077.e6. doi: 10.1016/j.jaip.2021.04.016. Epub 2021 Apr 22. J Allergy Clin Immunol Pract. 2021. PMID: 33895362 Free article. Clinical Trial.

2

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease.

Zhong N, Zheng J, Wen F, Yang L, Chen P, Xiu Q, Yao W, Sun T, Zhao Z, Shen H, Shi Y, Lin J, Li Q. Zhong N, et al. Among authors: zheng j. Curr Med Res Opin. 2012 Feb;28(2):257-65. doi: 10.1185/03007995.2011.636420. Epub 2012 Jan 20. Curr Med Res Opin. 2012. PMID: 22046961 Clinical Trial.

3

Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes.

Guan W, Zheng J, Gao Y, Jiang C, Xie Y, An J, Yu X, Liu W, Zhong N. Guan W, et al. Among authors: zheng j. J Allergy Clin Immunol. 2013 Feb;131(2):332-8.e1-4. doi: 10.1016/j.jaci.2012.08.020. Epub 2012 Oct 4. J Allergy Clin Immunol. 2013. PMID: 23040886 Clinical Trial.

4

Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Zheng J, de Guia T, Wang-Jairaj J, Newlands AH, Wang C, Crim C, Zhong N. Zheng J, et al. Curr Med Res Opin. 2015 Jun;31(6):1191-200. doi: 10.1185/03007995.2015.1036016. Curr Med Res Opin. 2015. PMID: 25830381 Clinical Trial.

5

The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial).

Zheng J, Zhong N, Wang C, Huang Y, Chen P, Wang L, Hui F, Zhao L, Wang H, Luo L, Du X, Han Goh A, Lipson DA. Zheng J, et al. COPD. 2018 Jun-Aug;15(4):334-340. doi: 10.1080/15412555.2018.1481022. Epub 2018 Sep 28. COPD. 2018. PMID: 30265816 Free article. Clinical Trial.

6

Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials.

Zheng J, Xu JF, Jenkins M, Assam PN, Wang L, Lipworth BJ. Zheng J, et al. Respir Res. 2020 Mar 12;21(1):69. doi: 10.1186/s12931-020-1332-3. Respir Res. 2020. PMID: 32164675 Free PMC article. Clinical Trial.

7

Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study.

Zhong N, Zheng J, Lee SH, Lipson DA, Du X, Wu S. Zhong N, et al. Among authors: zheng j. Int J Chron Obstruct Pulmon Dis. 2020 Apr 17;15:809-819. doi: 10.2147/COPD.S215011. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32368027 Free PMC article. Clinical Trial.

8

Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.

O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK. O'Byrne PM, et al. Among authors: zheng j. Lancet Respir Med. 2021 Feb;9(2):149-158. doi: 10.1016/S2213-2600(20)30416-1. Epub 2020 Oct 1. Lancet Respir Med. 2021. PMID: 33010810 Clinical Trial.

9

Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.

FitzGerald JM, O'Byrne PM, Bateman ED, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Larsdotter U, Emerath U, Jansen G, Puu M, Alagappan VKT, Surmont F, Reddel HK. FitzGerald JM, et al. Among authors: zheng j. Drug Saf. 2021 Apr;44(4):467-478. doi: 10.1007/s40264-020-01041-z. Epub 2021 Feb 6. Drug Saf. 2021. PMID: 33548020 Free PMC article. Clinical Trial.

10

Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2.

Bateman ED, O'Byrne PM, FitzGerald JM, Barnes PJ, Zheng J, Lamarca R, Puu M, Parikh H, Alagappan V, Reddel HK. Bateman ED, et al. Among authors: zheng j. Ann Am Thorac Soc. 2021 Dec;18(12):2007-2017. doi: 10.1513/AnnalsATS.202011-1386OC. Ann Am Thorac Soc. 2021. PMID: 33979557 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,704 results

Search Page

Filters